1. A phase 2 multicentre study of siltuximab, an anti‐interleukin‐6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. (25th February 2013) Authors: Voorhees, Peter M.; Manges, Robert F.; Sonneveld, Pieter; Jagannath, Sundar; Somlo, George; Krishnan, Amrita; Lentzsch, Suzanne; Frank, Richard C.; Zweegman, Sonja; Wijermans, Pierre W.; Orlowski, Robert Z.; Kranenburg, Britte; Hall, Brett; Casneuf, Tineke; Qin, Xiang; van de, Helgi; Xie, Hong; T... Journal: British journal of haematology Issue: Volume 161:Number 3(2013:May) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development and validation of panoptic Meso scale discovery assay to quantify total systemic interleukin‐6. (4th June 2015) Authors: Chaturvedi, Shalini; Siegel, Derick; Wagner, Carrie L.; Park, Jaehong; van de Velde, Helgi; Vermeulen, Jessica; Fung, Man‐Cheong; Reddy, Manjula; Hall, Brett; Sasser, Kate Journal: British journal of clinical pharmacology Issue: Volume 80:Number 4(2015:Oct.) Page Start: 687 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗